Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ElevateBio
Biotech
After massive $401M raise, ElevateBio lets 13% of staff go
Even with $401 million in the bank, ElevateBio is still shaving off some preclinical work resulting in layoffs to 13% of the workforce.
Annalee Armstrong
,
Max Bayer
Oct 26, 2023 11:20am
ElevateBio hits 2023 high with $401M series D
May 24, 2023 6:00am
Moderna taps Life Edit to develop next-gen gene therapies
Feb 22, 2023 7:00am
2 Astellas execs to retire—Chutes & Ladders
Aug 5, 2022 9:46am
ElevateBio, Boston Children's Hospital collab on new CAR-T biz
Aug 4, 2022 11:00am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
